| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ORBOTECH LTD | 214,922 | 4,470,000 | 0.44% | ||
| 52 | ALNYLAM PHARMACEUTICALS INC | 37,000 | 4,435,000 | 0.43% | ||
| 53 | RELYPSA INC | 132,000 | 4,368,000 | 0.43% | ||
| 54 | KEMPHARM INC | 237,500 | 4,363,000 | 0.43% | ||
| 55 | INTERCEPT PHARMACEUTICALS INCORPORATED | 17,500 | 4,224,000 | 0.41% | ||
| 56 | GENOCEA BIOSCIENCES INC | 302,200 | 4,149,000 | 0.41% | ||
| 57 | INTRA-CELLULAR THERAPIES INC | 128,000 | 4,090,000 | 0.40% | ||
| 58 | Biotie Therapies Corp. | 196,800 | 3,930,000 | 0.38% | ||
| 59 | SPDR INDEX SHS FDS | 104,920 | 3,927,000 | 0.38% | ||
| 60 | PORTOLA PHARMACEUTICALS INC | 86,000 | 3,917,000 | 0.38% | ||
| 61 | MEDIVATION INC | 34,115 | 3,896,000 | 0.38% | ||
| 62 | FOAMIX PHARMACEUTICALS LTD | 380,000 | 3,895,000 | 0.38% | ||
| 63 | DEPOMED INC | 180,000 | 3,863,000 | 0.38% | ||
| 64 | Nivalis Therapeutics Inc | 255,000 | 3,863,000 | 0.38% | ||
| 65 | Receptos Inc | 20,000 | 3,801,000 | 0.37% | ||
| 66 | Sunesis Pharmaceuticals I | 1,235,000 | 3,717,000 | 0.36% | ||
| 67 | Life Technologies Corp | 209,027 | 3,696,000 | 0.36% | ||
| 68 | A O SMITH | 50,620 | 3,644,000 | 0.36% | ||
| 69 | SPDR SER TR | 80,080 | 3,536,000 | 0.35% | ||
| 70 | DYNAVAX TECHNOLOGIES CORP | 150,000 | 3,514,000 | 0.34% | ||
| 71 | SAGE THERAPEUTICS INC | 48,000 | 3,504,000 | 0.34% | ||
| 72 | KITE PHARMA INCORPORATED | 56,970 | 3,473,000 | 0.34% | ||
| 73 | Marinus Pharmaceuticals Inc | 298,533 | 3,463,000 | 0.34% | ||
| 74 | Arrowhead Pharma Inc | 475,000 | 3,396,000 | 0.33% | ||
| 75 | HALOZYME THERAPEUTICS INC | 150,000 | 3,387,000 | 0.33% | ||
| 76 | OCULAR THERAPEUTIX INC | 160,000 | 3,365,000 | 0.33% | ||
| 77 | Pieris Pharmaceuticals | 1,200,000 | 3,300,000 | 0.32% | ||
| 78 | RAPTOR PHARMACEUTICAL CORP | 206,500 | 3,261,000 | 0.32% | ||
| 79 | THERAPEUTICSMD INC | 412,500 | 3,242,000 | 0.32% | ||
| 80 | MACROGENICS INC | 85,000 | 3,227,000 | 0.32% | ||
| 81 | TRILLIUM THERAPEUTICS INC | 147,000 | 3,208,000 | 0.31% | ||
| 82 | PTC THERAPEUTICS INC | 66,500 | 3,201,000 | 0.31% | ||
| 83 | ACCELERON PHARMA INC | 100,000 | 3,164,000 | 0.31% | ||
| 84 | VERIFONE SYS INC | 93,055 | 3,160,000 | 0.31% | ||
| 85 | UNIQURE NV | 115,000 | 3,105,000 | 0.30% | ||
| 86 | FIVE PRIME THERAPEUTICS INC | 125,000 | 3,105,000 | 0.30% | ||
| 87 | APPLIED GENETIC TECHNOL CORP | 200,124 | 3,070,000 | 0.30% | ||
| 88 | MELLANOX TECHNOLOGIES LTD | 62,850 | 3,054,000 | 0.30% | ||
| 89 | Tekmira Pharmaceuticals Corp. | 255,000 | 3,024,000 | 0.30% | ||
| 90 | MIRATI THERAPEUTICS INC COM | 95,000 | 2,990,000 | 0.29% | ||
| 91 | APPLE INC | 23,223 | 2,913,000 | 0.29% | ||
| 92 | IMMUNE DESIGN CORP | 140,000 | 2,891,000 | 0.28% | ||
| 93 | PTC THERAPEUTICS INC | 600 | 2,888,000 | 0.28% | Call | |
| 94 | STARBUCKS CORP | 53,583 | 2,873,000 | 0.28% | ||
| 95 | MEDICINES CO | 1,000 | 2,861,000 | 0.28% | Call | |
| 96 | Carbylan Therapeutics Inc. | 400,000 | 2,860,000 | 0.28% | ||
| 97 | WIX COM LTD | 120,305 | 2,842,000 | 0.28% | ||
| 98 | CYTOKINETICS INC | 422,250 | 2,838,000 | 0.28% | ||
| 99 | COLUCID PHARMACEUTICALS ORD | 317,250 | 2,824,000 | 0.28% | ||
| 100 | IONIS PHARMACEUTICAL | 48,000 | 2,762,000 | 0.27% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-002526, filed 2015.08.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
